BillionaireNet
Leitner
Wolfgang Leitner
Rank #1270
AUSTRIAConstruction & EngineeringEngineering

Wolfgang Leitner

Net Worth
$3.187B
+1.47% (24h)
Wolfgang Leitner, born in 1953, is an Austrian billionaire and a prominent figure in the engineering and construction industry. As the former CEO of Andritz AG, a leading plant engineering company, he spearheaded its global expansion and solidified its position in the market. Leitner earned a doctorate in chemistry from the University of Graz, laying the foundation for his successful career. His net worth is estimated at $3.0 billion, reflecting his strategic leadership and achievements. He is married and has two children. Leitner's career includes founding and selling the pharmaceutical company Genericon Pharma. He also acquired a significant stake in Andritz AG, contributing to its growth and success.

The Full Dossier

Early Life

Wolfgang Leitner was born in Graz, Austria, in 1953. His father worked as a metal worker for Andritz AG. Leitner developed a passion for science and engineering from an early age, which led him to excel in his studies. He earned a doctorate in chemistry from the University of Graz in 1978.

Rise to Success

After graduating, Leitner started his career at Vianova, an Austrian subsidiary of Hoechst AG, where he worked in research. In 1981, he joined McKinsey & Company as a management consultant. In 1986, he founded the pharmaceutical company Genericon Pharma with a classmate, Martin Bartenstein. Genericon Pharma was later sold to Bristol-Myers Squibb for $110 million. Leitner joined Andritz AG as CFO in 1987. In 1994, he became CEO, a role he held until 2022. Under his leadership, Andritz AG grew into a global leader in plant engineering.

Key Business Strategies

Leitner spearheaded Andritz AG's expansion through strategic acquisitions and a focus on technological innovation. He took a 26% stake in the company in 1999. His ability to identify and integrate companies, such as the acquisition of Xerium Technologies in 2018 for $833 million, was key to Andritz's growth. His leadership transformed Andritz into one of Austria's largest companies.

Philanthropy

No specific philanthropy amounts are available in the search results.

Career Timeline

2022

Moved to Supervisory Board

Stepped down as CEO of Andritz AG and moved to the supervisory board.

1994

CEO of Andritz AG

Became the Chief Executive Officer of Andritz AG.

1987

CFO of Andritz AG

Joined Andritz AG as Chief Financial Officer.

1986

Founder of Genericon Pharma

Founded Genericon Pharma, a pharmaceutical company.

1981

Management Consultant

Began working as a management consultant at McKinsey & Company.

1978

Doctorate in Chemistry

Received a doctorate in chemistry from the University of Graz, Austria.

Philanthropic Impact

Not AvailableUndisclosed

Not Available

No specific philanthropy amounts available in the search results.

Wealth Trajectory